AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Whitehall editor Kate Devlin question why ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Investing.com -- AIM ImmunoTech (NYSE: AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...

AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from ...

How an agreement set up by the Tories and lauded by Labour fell victim to cost-cutting and UK curbs on drugs expenditure ...

Find insight on Siemens Healthineers , Eli Lilly, AstraZeneca, and more in the latest Market Talks covering Health Care.

A Liberal Democrat peer has accused the government of favouring the south-east of England over Merseyside after AstraZeneca ...

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...

The boss of drugmaker AstraZeneca has said he was "very disappointed"” with the firm’s move to scrap plans for a £450 million vaccine plant in Liverpool, ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

AstraZeneca has halted plans to build a £450 million vaccine plant in the UK due to decreased government support, prompting ...